S'abonner à DNDi_HQ sur Twitter
Connect to Fight Neglect: DNDi has launched a special website for its 10-year anniversary, dedicated to the voices of all actors in neglected disease R&D. We hope that YOU will connect to share your story as well!

Over 1 billion people, including 500 million children, in the poorest regions of the world, are affected by neglected diseases that debilitate, disfigure or kill.

DNDi was created to respond to the medical needs of millions of neglected patients. DNDi’s vision is to improve their quality of life and health.

DNDi develops and delivers new treatments to combat neglected diseases.

DNDi’s research and development approach is driven by the real day-to-day needs of patients and healthcare providers.

By connecting public and private partners, DNDi synergizes expertise and capitalizes upon the best science. 

DNDi also works to strengthen the health R&D field in the countries where the diseases occur in order to reinforce capacities for sustainable change.

Major progress has been made in the short-term with six new treatments made available to forgotten patients since the creation of DNDi, in 2003.

However, major breakthroughs are still needed to treat patients: Entirely new, affordable, and adapted drugs will change the lives of millions of people.

SPOTLIGHT
«
»

DNDi's 10 YEARS

The ‘Connect to Fight Neglect’ campaign highlight the voices of all actors in neglected disease R&D, from patients and advocates, to the health workforce and public health experts, to private companies and governments. Join in! More

CHAGAS DISEASE

The soccer star Lionel Messi, having seen the Ricardo Preve documentary 'Chagas, A Silent Killer', speaks out about Chagas disease and calls for teamwork to treat patients and find altogether new treatments. More

MSF/DNDi EVENT

13-14 December, New York / Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations. Access the entire webcast, session by session ! More

SLEEPING SICKNESS

Fexinidazole: launch of Phase II/III clinical trial in the Democratic Republic of Congo and Central African Republic.The study, initiated by DNDi and its partners, will test the efficacy and safety of fexinidazole, with once daily tablets for ten days. More

PAEDIATRIC HIV

Testimonies of South African mothers: demonstrating the difficulties in administering current treatments for paediatric HIV More

LEISHMANIASIS

Voices for neglected diseases. Lemarus Tebakwani Lukeno has been treated with SSG&PM for kala-azar; read his and other patient stories More

MALARIA

200 million treatments of ASAQ, DNDi’s antimalarial combination therapy of Artesunate and Amodiaquine, have been distributed in over 30 countries since its launch in 2007 ! More

DNDi NEWS

   

May 13-17, 2013
World Leish 5
Porto de Galinhas, Pernambuco, Brazil
The Fifth World Leishmaniasis Congress is organized by the Oswaldo Cruz Foundation, 
the Brazilian Society of Tropical Medicine, the Brazilian Society of Protozoology, and the
Brazilian Society of Parasitology.

June 4-5, 2013
A Decade of R&D for Neglected Diseases in Africa
Nairobi, Kenya
On the occasion of DNDi’s 10th anniversary, DNDi and founding partner KEMRI bring together key African decision-makers and public health actors for this special event to explore the challenges and opportunities for research & development for neglected diseases in Africa - past and future!

See all events

DNDI WORLDWIDE



Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License